A Correlation Study of Birthing Ball Technique and Sacral Massage on Maternal and Fetal Well-being Among Parturient Women: A Non-Randomized Clinical Trail.

Background: A woman's pregnancy might be challenging because there are so many changes happening at the time. Most women who give birth have severe labor pain. Women typically use a number of coping strategies, including both pharmaceutical and non-pharmacological, or more natural, techniques, to minimize labor discomfort.

Searching for the cellular underpinnings of the selective vulnerability to tauopathic insults in Alzheimer's disease.

Neurodegenerative diseases such as Alzheimer's disease exhibit pathological changes in the brain that proceed in a stereotyped and regionally specific fashion. However, the cellular underpinnings of regional vulnerability are poorly understood, in part because whole-brain maps of a comprehensive collection of cell types have been inaccessible. Here, we deployed a recent cell-type mapping pipeline, Matrix Inversion and Subset Selection (MISS), to determine the brain-wide distributions of pan-hippocampal and neocortical cells in the mouse, and then used these maps to identify general principles of cell-type-based selective vulnerability in PS19 mouse models.

Cancer History, Antiphospholipid Syndrome, and Lupus Anticoagulant: A Perfect Storm for Thrombosis.

Cancer and antiphospholipid syndrome (APS) independently increase thrombotic risk, and their coexistence can create a particularly hazardous prothrombotic state. This case report aims to highlight the complex challenges in managing concurrent thrombotic and hemorrhagic events in patients with a history of cancer and APS. The combination of these conditions presents a rare and difficult clinical scenario, requiring careful consideration in anticoagulation management.

Conflicts of Interest in Clinical Practice: Cleveland Clinic Policy and Experience.

The Cleveland Clinic Innovation Management and Conflict of Interest ("IM&COI") Program implemented a policy on Conflicts of Interest in Clinical Practice in 2013. The policy requires review of financial interests greater than $20,000 in a year, or more than 5% equity in a company, when the clinician is prescribing or using products of the company with which they have a relationship. The IM&COI Committee developed definitions for low, medium and high levels of annual compensation and risk and uses a "Matrix" to guide disclosure based on these factors.